C-MAP CARFILZOMIB MYELOMA ACCESS PROGRAM Trademark

Trademark Overview

On Monday, August 29, 2011, a trademark application was filed for C-MAP CARFILZOMIB MYELOMA ACCESS PROGRAM with the United States Patent and Trademark Office. The USPTO has given the C-MAP CARFILZOMIB MYELOMA ACCESS PROGRAM trademark a serial number of 85410049. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 21, 2014. This trademark is owned by Onyx Pharmaceuticals, Inc.. The C-MAP CARFILZOMIB MYELOMA ACCESS PROGRAM trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Charitable services, namely, patient assistance program to provide prescription drugs to low income patients
c-map carfilzomib myeloma access program

General Information

Serial Number85410049
Word MarkC-MAP CARFILZOMIB MYELOMA ACCESS PROGRAM
Filing DateMonday, August 29, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 21, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 24, 2012

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"CARFILZOMIB MYELOMA ACCESS PROGRAM"
Description of MarkThe mark consists of the words "C-MAP CARFILZOMIB MYELOMA ACCESS PROGRAM" with the word "C-MAP" in large letters above the words "CARFILZOMIB MYELOMA ACCESS PROGRAM" in smaller letters below "C-MAP". Behind the word "C-MAP" is a path that diminishes in size.
Goods and ServicesCharitable services, namely, patient assistance program to provide prescription drugs to low income patients

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 1, 2011
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOnyx Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameOnyx Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Monday, April 21, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, April 21, 2014ABANDONMENT - NO USE STATEMENT FILED
Thursday, February 20, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 20, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, October 19, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 18, 2013EXTENSION 2 GRANTED
Tuesday, September 17, 2013EXTENSION 2 FILED
Friday, October 11, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 17, 2013TEAS EXTENSION RECEIVED
Wednesday, March 20, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 18, 2013EXTENSION 1 GRANTED
Monday, March 18, 2013EXTENSION 1 FILED
Monday, March 18, 2013TEAS EXTENSION RECEIVED
Friday, March 15, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 18, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 24, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 24, 2012PUBLISHED FOR OPPOSITION
Wednesday, July 4, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 19, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, June 13, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 13, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 12, 2012TEAS AMENDMENT OF USE RECEIVED
Tuesday, June 12, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, June 9, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 8, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 8, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 20, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 20, 2011NON-FINAL ACTION E-MAILED
Tuesday, December 20, 2011NON-FINAL ACTION WRITTEN
Thursday, December 15, 2011ASSIGNED TO EXAMINER
Thursday, September 29, 2011PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Thursday, September 22, 2011ASSIGNED TO LIE
Wednesday, September 21, 2011TEAS VOLUNTARY AMENDMENT RECEIVED
Friday, September 2, 2011NOTICE OF DESIGN SEARCH CODE MAILED
Thursday, September 1, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, September 1, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

program access myeloma carfilzomib prescription drugs income patients provide services namely patient assistance